Status:
TERMINATED
Differences in Immunologic Response to Cryoablation Versus Radiofrequency Ablation in the Treatment of Renal Cell Carcinoma
Lead Sponsor:
University of California, Irvine
Conditions:
Immune Response to 3 Approaches
Eligibility:
MALE
18-99 years
Brief Summary
The purpose of this study is to compare changes in the body's self-defense (immune response) after two different treatments for small kidney tumors: 1) Cryoablation (freezing) therapy in which the tum...
Eligibility Criteria
Inclusion
- You are eligible to participate in this study if you are an adult (older than 18 years)
- Diagnosed with renal cell cancer 1-3 centimeters in size on the CT scan.
Exclusion
- You are not eligible to participate in this study if you are immune compromised (chemotherapy,corticosteroid use, HIV \[as documented in your medical record\], etc.)
- Have an autoimmune disorders (Rheumatoid arthritis, Crohn's disease, etc)
- Have a tumor larger than 4 cm
- Are pregnant.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03409224
Start Date
January 1 2003
End Date
April 1 2019
Last Update
April 19 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.